Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Investra-24hs
WARNING LETTER
•Investra-24hs

Investra-24hs – FDA Warning Letter

Record Details

The FDA issued a Warning Letter to Investra-24hs for offering unapproved new drugs and misbranded drugs for sale on multiple websites, violating sections 301(a), 301(d), 503(b), and 505(a) of the FD&C Act. The FDA reviewed the listed websites and determined products like "Generic Meridia (Sibutramine)" are unapproved new drugs because they lack FDA approval and are not generally recognized as safe and effective. Meridia (sibutramine) was voluntarily withdrawn from the U.S. market in 2010 due to increased risks of heart attack and stroke.

Additionally, these products are misbranded under section 502(f)(1) of the FD&C Act because they lack adequate directions for use by a layperson, as they are prescription drugs requiring professional supervision. The FDA emphasized the inherent risk to consumers from unapproved and misbranded drugs, which may be contaminated, counterfeit, or contain incorrect ingredients. Investra-24hs is required to immediately cease marketing violative drug products and notify the FDA within 10 working days of steps taken to correct these violations and prevent recurrence. Failure to comply may result in regulatory actions such as seizure or injunction.

Company
Investra-24hs
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Thomas (TJ) Christl (Office Director)
View Company Profile

ID · 5be554a9-9c06-4e83-a84c-908bb66f9b40

Violation Codes9
21 U.S.C. 321(g)21 U.S.C. 331(d)21 U.S.C. 353(b)21.U.S.C. 355(a)21 U.S.C. 321(p)21 U.S.C. 352(f)(1)21 CFR 201.521 CFR 201.11521 U.S.C. 331(a)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Investra-24hs
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.